Rinal Patel

Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial

Nicholas Turner, Smitha Zaharoff, Heather A. King et al. · Trials · 2022 · 52 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Dalbavancin for Treatment of <i>Staphylococcus aureus</i> Bacteremia

Nicholas Turner, Toshimitsu Hamasaki, Sarah B. Doernberg et al. · JAMA · 2025 · 33 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

The Safety and Efficacy of Dalbavancin and Active Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections

Manana Giorgobiani, Margaret Burroughs, Tinatin Antadze et al. · The Pediatric Infectious Disease Journal · 2022 · 19 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +15

Tuberculous Empyema Presenting as a Persistent Chest Wall Mass: Case Report

Jennifer Madeo, Rinal Patel, Wondwossen Gebre et al. · GERMS · 2013 · 17 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +14

The human promyelocytic leukemia protein is a tumor suppressor for murine skin carcinogenesis

Victoria M. Virador, Rafael E. Flores‐Obando, Adam Berry et al. · Molecular Carcinogenesis · 2008 · 10 citations · Full text

Medicine, Dermatology, Oncology +13